Avigen, Inc. Reports Third Quarter 2008 Financial Results

ALAMEDA, Calif., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its third quarter ended September 30, 2008. At September 30, 2008, Avigen had approximately $56 million in financial assets, including cash, cash equivalents, and available-for-sale securities and restricted investments, compared with approximately $78 million at December 31, 2007. More complete financial results are detailed in the financial tables below.